宏源药业：2025年第三季度报告

Core Insights - The company reported a revenue of 434,517,125.34 yuan for Q3 2025, representing a year-on-year growth of 2.45% [1] - The net profit attributable to shareholders reached 4,710,268.28 yuan, showing a significant year-on-year increase of 1,316.05% [1] Financial Performance - Revenue for Q3 2025: 434.52 million yuan, up 2.45% year-on-year [1] - Net profit for Q3 2025: 4.71 million yuan, up 1,316.05% year-on-year [1]